您的位置: 首页 > 农业专利 > 详情页

LAQUINIMOD POUR REDUIRE UN DOMMAGE THALAMIQUE DANS LA SCLEROSE EN PLAQUES
专利权人:
TEVA PHARMACEUTICAL INDUSTRIES LTD.
发明人:
COMI, GIANCARLO,ROCCA, MARIA ASSUNTA,FILIPPI, MASSIMO
申请号:
CA2884272
公开号:
CA2884272A1
申请日:
2013.10.09
申请国别(地区):
CA
年份:
2014
代理人:
摘要:
This invention provides methods for inhibiting or reducing thalamic damage in a subject comprising administering to the subject an amount of laquinimod, wherein the subject is a human patient afflicted with a form of multiple sclerosis or presenting a clinically isolated syndrome who has been determined to have thalamic damage at baseline, a subject afflicted with a disease or disorder other than a form of multiple sclerosis or a clinically isolated syndrome, or a subject not afflicted with a form of multiple sclerosis or a presenting clinically isolated syndrome, and laquinimod and laquinimod pharmaceutical compositions for use thereof. This invention also provides methods for inhibiting or reducing tremor or spasticity in a subject afflicted by tremor or spasticity, comprising administering to the subject an amount of laquinimod, and laquinimod and laquinimod pharmaceutical compositions for use thereof.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充